71
Central Labs & Imaging
Clinical Trial Operating System
1
Welcome
2
How to Use This System in Practice
3
About the Author
4
Clinical Trial Lifecycle
5
Trial Phases & Objectives
6
CRA Role Across the Lifecycle
7
Lifecycle to Binder Map
8
Regulatory Compliance
9
Regulatory Framework & Roles
10
Essential Documents & Site Regulatory Binder
11
Informed Consent Oversight
12
IRB/IEC & Approvals
13
Delegation, Training & Qualification
14
TMF Quality Control (CRA-Relevant)
15
Regulatory Templates & Checklists
16
Site Start-Up & Activation
17
Feasibility & Site Selection
18
Site Start-Up Workflow
19
Site Initiation Visit (SIV)
20
Site Activation & Readiness
21
Start-Up Risks & Mitigation
22
Start-Up Templates & Checklists
23
Monitoring Operations
24
Monitoring Visit Types
25
Monitoring Workflow
26
Source Data Verification & Risk-Based Monitoring
27
Follow-Up & Issue Management
28
Monitoring Templates
29
Safety & Pharmacovigilance
30
Safety Framework & Roles
31
AE & SAE Identification and Reporting
32
Causality, Severity & Expectedness
33
Safety Oversight Workflows
34
Safety Follow-Up & Escalation
35
Safety Templates & Checklists
36
Data Quality & Analytics
37
Data Quality Framework
38
Key CRA Metrics
39
Risk-Based Monitoring (RBM) Analytics
40
Site Performance Dashboards
41
Query & Issue Trending
42
Analytics Templates
43
Protocol Deviations & CAPA
44
Deviation Framework & Definitions
45
Deviation Identification & Documentation
46
Classification & Impact Assessment
47
CAPA Workflow & Root Cause Analysis
48
Trending & Systemic Risk
49
Deviation & CAPA Templates
50
Project Management in Clinical Trials
51
Trial Planning & Milestones
52
Governance & Communication
53
Risk & Issue Management
54
Resource & Capacity Planning
55
Delivery Metrics & KPIs
56
PM Templates & Trackers
57
Inspection Readiness & Audit Defense
58
Inspection Types & Stakeholders
59
Inspection Readiness Framework
60
Pre-Inspection Preparation
61
On-Site Inspection Support
62
Findings, Responses & Remediation
63
Mock Inspections & Training
64
Inspection Templates & Checklists
65
Oncology Operations Appendix
66
Oncology Trial Designs
67
RECIST & Tumor Assessment
68
Dose-Limiting Toxicity & Escalation
69
Immune-Related Adverse Events (irAEs)
70
Oncology Safety Workflows
71
Central Labs & Imaging
72
Oncology Inspection Hotspots
73
Oncology Quick Reference
74
Vaccine Trials Operations Appendix
75
Vaccine Trials Quick Reference
76
Vaccine Trials Quick Reference
77
Vaccine Trials Quick Reference
78
Vaccine Trials Quick Reference
79
Case Studies
80
Case Study: Enrollment Underperformance
81
Case Study: Late SAE Reporting
82
Case Study: Inspection Finding – Data Quality & Source Documentation
Table of contents
71.1
Oncology Dependencies
71.2
CRA Oversight
71
Central Labs & Imaging
71.1
Oncology Dependencies
Central pathology review
Central biomarker labs
Central imaging review (CT/MRI/PET)
71.2
CRA Oversight
Sample chain-of-custody
Imaging manuals followed
Lab turnaround times
Specimen integrity
70
Oncology Safety Workflows
72
Oncology Inspection Hotspots